Trial Profile
Investigator-initiated Phase I trial of TCR-modified T cells.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Nov 2016
Price :
$35
*
At a glance
- Drugs TCR-transduced lymphocytes (Primary)
- Indications Autoimmune disorders; T-cell leukaemia
- Focus Therapeutic Use
- 26 Nov 2016 New trial record